Treatment Cost

SAN DIEGO — More research is needed to determine drivers of inhaler costs and patient knowledge on available financial assistance, according to a poster presentation here.

I read with great interest the blog “Avastin W” by John A. Hovanesian, whom I would like to congratulate for touching on a delicate argument that affects the quality of life of individuals affected by macular and retinal diseases.

In-office procedures are an integral part of modern dry eye disease management for general practices and specialty clinics alike.

Key takeaways:

More patients without continuous airway positive pressure coverage in their region said that cost affected their choice of treatment than patients with CPAP coverage, according to results published in Annals of the American Thoracic Society.

In this video, Jonathan Wadsley, MA, MRCP, FRCR, a consultant clinical oncologist at Weston Park Hospital in Sheffield, U.K., discussed financial toxicity associated with thyroid cancer diagnosis.

Black patients with chronic kidney disease may be less likely to adhere to medical treatment compared with non-Black patients due to the financial burden medical care puts on available funds for basic needs, according to a study.

Healio spoke with Jonathan M. Gerber, MD, of the Center for Cancer Excellence at the University of Massachusetts Medical School and UMass Memorial Health Care System, and HemOnc Today Editorial Board member, about the underrecognized burden of high treatment costs in AML.

Patients with head and neck cancer who reported high financial toxicity at baseline appeared nearly twice as likely to experience poor outcomes, according to study results published in Oral Oncology.

Medication affordability is a major issue in the United States. CMS estimates U.S. prescription drug expenditure was $335 billion in 2018, and recent studies have shown that the cost of prescription drugs is surging faster than any other medical service or good.